Loading organizations...
Biotechnology company developing treatments through cytoprotection.
Zytoprotec has raised $2.7M across 1 funding round.
Zytoprotec has raised $2.7M in total across 1 funding round.
Zytoprotec has raised $2.7M in total across 1 funding round.
Zytoprotec's investors include Norbert Rieidel.
Zytoprotec has raised $2.7M across 1 funding round. Most recently, it raised $2.7M Series A in January 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 29, 2013 | $2.7M Series A | Norbert Rieidel |